A Trial of Doxycycline vs. Standard Supportive Therapy in Newly-diagnosed Cardiac AL Amyloidosis Patients Undergoing Bortezomib-based Therapy

NCT03474458 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped difficulty in recruitment

Conditions

Cardiac AL Amyloidosis

Interventions

DRUG: Doxycycline
DRUG: Standard of care therapy

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia